Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Return on Sales [ROS] (2025)

Updated

Black Diamond Therapeutics' Return on Sales [ROS] was 17.89% in Q4 2025, up 0.95 percentage points from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Return on Sales [ROS] (2025) Analysis & Trends

From Q1 2025 onward, Black Diamond Therapeutics has reported Return on Sales [ROS] for 4 quarters.

  • Quarterly Return on Sales [ROS] has moved between 6.72% (Q2 2025) and 77.90% (Q1 2025) over five years.
  • Per Business Quant data, BDTX's Return on Sales [ROS] in the three quarters before Q4 2025 was 16.94% (Q3 2025), 6.72% (Q2 2025) and 77.90% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 24.35%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 37.86%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 20.57%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 34.95%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -133.21%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 28.37%
10 Black Diamond Therapeutics 119.49 Mn -373.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17.89%
Sep 30, 2025 16.94%
Jun 30, 2025 6.72%
Mar 31, 2025 77.90%
API Access

Black Diamond Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BDTX&period=max&api_key=YOUR_API_KEY